{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:21:31Z","timestamp":1787494891283,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11822-5","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:54:33Z","timestamp":1761659673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Viral hepatitis B co-infection among people living with HIV: a National cross-sectional survey in Togo in 2023"],"prefix":"10.1186","volume":"25","author":[{"given":"Rom\u00e9o M\u00e8d\u00e9ss\u00e8","family":"Togan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric Iman","family":"Youa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogatien Comlan","family":"Atoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malanna","family":"Bigma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodion Yao","family":"Konu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold Junior","family":"Sadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Kouame","family":"Tchankoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alassane OURO","family":"Medeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumarou I Wone","family":"Adama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palokinam","family":"Pitche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Wandeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier Koumavi","family":"Ekouevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claver Anoumou","family":"Dagnra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"2","key":"11822_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97\u2013107. https:\/\/doi.org\/10.1046\/j.1365-2893.2003.00487.x.","journal-title":"J Viral Hepat"},{"issue":"Suppl 1","key":"11822_CR2","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.4314\/ahs.v11i3.70065","volume":"11","author":"P Ocama","year":"2011","unstructured":"Ocama P, Opio KC, Kagimu M, Seremba E, Wabinga H, Colebunders R. Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda. Afr Health Sci. 2011;11(Suppl 1):S20\u20133. https:\/\/doi.org\/10.4314\/ahs.v11i3.70065.","journal-title":"Afr Health Sci"},{"key":"11822_CR3","doi-asserted-by":"crossref","unstructured":"Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. sept 2014;18:12:145.","DOI":"10.1186\/s12916-014-0145-y"},{"key":"11822_CR4","doi-asserted-by":"crossref","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Lond Engl. 10 janv 2015;385(9963):117\u201371.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"11822_CR5","unstructured":"World Health Organization. Fact-sheets: viral hepatitis B. [Online]. 2024. [Accessed on February 20, 2024]. Available at: https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"issue":"1","key":"11822_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/jvh.13615","volume":"29","author":"A Ram\u00edrez Mena","year":"2022","unstructured":"Ram\u00edrez Mena A, Tine JM, Fortes L, Ndiaye O, Ka D, Ngom NF, et al. Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal. J Viral Hepat Janv. 2022;29(1):60\u20138.","journal-title":"J Viral Hepat Janv"},{"key":"11822_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12879-017-2422-9","volume":"17","author":"J Umutesi","year":"2017","unstructured":"Umutesi J, Simmons B, Makuza JD, Dushimiyimana D, Mbituyumuremyi A, Uwimana JM, et al. Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda. BMC Infect Dis 2 Mai. 2017;17:315.","journal-title":"BMC Infect Dis 2 Mai"},{"issue":"3","key":"11822_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jvh.13217","volume":"27","author":"L Platt","year":"2020","unstructured":"Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, et al. Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta\u2010analysis. J Viral Hepat Mars. 2020;27(3):294.","journal-title":"J Viral Hepat Mars"},{"issue":"12","key":"11822_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259891","volume":"16","author":"AM Bitty-Anderson","year":"2021","unstructured":"Bitty-Anderson AM, Ferr\u00e9 V, Gbeasor-Komlanvi FA, Tchankoni MK, Sadio A, Salou M, et al. Prevalence of hepatitis B and C among female sex workers in Togo, West Africa. PLoS ONE. 2021;16(12):e0259891.","journal-title":"PLoS ONE"},{"key":"11822_CR10","unstructured":"Conseil National de Lutte Contre le Sida et les Infections Sexuellement Transmissibles (CNLS-IST). Rapport annuel de lutte contre le VIH et le SIDA en 2022. Disponible sur: https:\/\/cnlstogo.org\/cnls\/"},{"issue":"3","key":"11822_CR11","first-page":"294","volume":"29","author":"AJ Sadio","year":"2019","unstructured":"Sadio AJ, Gbeasor-Komlanvi FA, Konu YR, Sewu EK, Zida-Compaore W, Salou M, et al. Prevalence of HIV infection and hepatitis B and factors associated with them among men who had sex with men in Togo in 2017. Med Sante Trop 1 ao\u00fbt. 2019;29(3):294\u2013301.","journal-title":"Med Sante Trop 1 ao\u00fbt"},{"key":"11822_CR12","unstructured":"Ekouevi DK, Larrouy L, Gbeasor-Komlanvi FA, Mackiewicz V, Tchankoni MK, Bitty-Anderson AM, et al. Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo. BMC Infect Dis. 12(1):839."},{"issue":"6","key":"11822_CR13","first-page":"621","volume":"68","author":"E Agbenu","year":"2008","unstructured":"Agbenu E, Banla A, Kolou M, D\u2019Almeida A, Kpotsra A, Dorkenoo A, et al. [Serologic markers used for hepatitis B surveillance in togo: status report and action proposals]. Med Trop Rev Corps Sante Colon d\u00e9c. 2008;68(6):621\u20134.","journal-title":"Med Trop Rev Corps Sante Colon d\u00e9c"},{"key":"11822_CR14","doi-asserted-by":"crossref","unstructured":"Patassi A, Benaboud S, Landoh DE, Salou M, Dagnra AC, Saka B, et al. Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lom\u00e9, Togo: Prevalence and molecular consequences. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 10 mai 2016;106(6).","DOI":"10.7196\/SAMJ.2016.v106i6.10312"},{"key":"11822_CR15","volume-title":"R\u00e9vision 2010","author":"Organisation mondiale de la sant\u00e9","year":"2010","unstructured":"Organisation mondiale de la sant\u00e9. Th\u00e9rapie antir\u00e9trovirale pour l\u2019infection par Le VIH Chez Les adultes et Les adolescents: recommandations pour Une approche de sant\u00e9 publique. R\u00e9vision 2010. Gen\u00e8ve: OMS; 2010."},{"key":"11822_CR16","unstructured":"Programme national de lutte contre le SIDA et les IST. Guide de prise En charge globale des personnes vivant avec Le VIH. 2019. Togo Disponible Sur : https:\/\/www.differentiatedservicedelivery.org\/wp-content\/uploads\/Togo_HIV-Clinical-Guidelines_May-2019.pdf"},{"key":"11822_CR17","doi-asserted-by":"crossref","unstructured":"Lai CL, Yuen MF. Chronic hepatitis B\u2013new goals, new treatment. N Engl J Med 4 d\u00e9c. 2008;359(23):2488\u201391.","DOI":"10.1056\/NEJMe0808185"},{"issue":"1 Pt 2","key":"11822_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0399-8320(08)73258-5","volume":"32","author":"P Marcellin","year":"2008","unstructured":"Marcellin P, Asselah T, Lada O. [Treatment \u00ab\u202f\u00e0 La Carte\u202f\u00bb of chronic hepatitis B]. Gastroenterol Clin Biol. 2008;32(1 Pt 2):S1-5.","journal-title":"Gastroenterol Clin Biol"},{"key":"11822_CR19","doi-asserted-by":"crossref","unstructured":"Ndow G, Gore ML, Shimakawa Y, Suso P, Jatta A, Tamba S et al. Hepatitis B testing and treatment in HIV patients in The Gambia\u2014Compliance with international guidelines and clinical outcomes. PLoS ONE. 14 juin. 2017;12(6):e0179025.","DOI":"10.1371\/journal.pone.0179025"},{"issue":"1","key":"11822_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12879-020-4784-7","volume":"20","author":"F Li\u00e9geois","year":"2020","unstructured":"Li\u00e9geois F, Boyer S, Eymard-Duvernay S, Carrieri P, Kouanfack C, Domyeum J, et al. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM). BMC Infect Dis 15 Janv. 2020;20(1):49.","journal-title":"BMC Infect Dis 15 Janv"},{"key":"11822_CR21","unstructured":"Organisation Mondiale de Sant\u00e9 (OMS). Hepatitis B [En ligne]. 2021 [Cit\u00e9 le 30\/01\/2023]. Disponible sur: https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"key":"11822_CR22","unstructured":"World Health Organization. Viral hepatitis scorecard African region 2021. [Online] 2022 [accessed January 13, 2023]. Available at: https:\/\/www.afro.who.int\/sites\/default\/files\/2022-07\/Viral_Hepatatis_Scorecard_%20WHD%202022_0.pdf"},{"key":"11822_CR23","unstructured":"Dean AG, Sullivan KM, Soe MM. OpenEpi: open source epidemiologic statistics for public health, Version. www.OpenEpi.com. https:\/\/www.openepi.com\/Menu\/OE_Menu.htm"},{"key":"11822_CR24","first-page":"1","volume":"2","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Prequalification of in vitro diagnostics: first response HIV 1\u20132.O card test. Public Rep. 2020;2:1\u201323.","journal-title":"Public Rep"},{"key":"11822_CR25","first-page":"1","volume":"2","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Prequalification of in vitro diagnostics: INNO-LIA HIV I\/II score. Public Rep. 2020;2:1\u201319.","journal-title":"Public Rep"},{"key":"11822_CR26","unstructured":"World Health Organization. Prequalification of in vitro diagnostics: Bioline HBsAg WB1. Public Report. 2020; 4 : 1\u201312."},{"key":"11822_CR27","unstructured":"World Health Organization, Hepatitis B, Geneva. Switzerland. [Online] 2002. [accessed on 30\/01\/2024]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/67746"},{"issue":"1","key":"11822_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227776","volume":"15","author":"T Weitzel","year":"2020","unstructured":"Weitzel T, Rodr\u00edguez F, Noriega LM, Marcotti A, Duran L, Palavecino C, et al. Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: a cross-sectional serosurvey. PLoS ONE. 2020;15(1):e0227776. https:\/\/doi.org\/10.1371\/journal.pone.0227776.","journal-title":"PLoS ONE"},{"key":"11822_CR29","unstructured":"Kafeero HM, Ndagire D, Ocama P, Kudamba A, Walusansa A, Sendagire H. Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020. Arch Public Health Arch Belg Sante Publique. 18(1):167."},{"key":"11822_CR30","doi-asserted-by":"crossref","unstructured":"Tosun S, Ayg\u00fcn O, \u00d6zdemir H\u00d6, Korkmaz E, \u00d6zdemir D. The impact of economic and social factors on the prevalence of hepatitis B in Turkey. BMC Public Health. 22 mai. 2018;18(1):649.","DOI":"10.1186\/s12889-018-5575-6"},{"key":"11822_CR31","doi-asserted-by":"crossref","unstructured":"Kenfack-Momo R, Kenmoe S, Takuissu GR, Ebogo-Belobo JT, Kengne-Nd\u00e9 C, Mbaga DS et al. Epidemiology of hepatitis B virus and\/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis. PLoS ONE. 31 mai. 2022;17(5):e0269250.","DOI":"10.1371\/journal.pone.0269250"},{"key":"11822_CR32","doi-asserted-by":"crossref","unstructured":"McNaughton AL, Louren\u00e7o J, Bester PA, Mokaya J, Lumley SF, Obolski U et al. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis. PLOS Med. 21 avr. 2020;17(4):e1003068.","DOI":"10.1371\/journal.pmed.1003068"},{"key":"11822_CR33","doi-asserted-by":"crossref","unstructured":"Coffie PA, Patassi A, Doumbia A, Bado G, Messou E, Minga A, et al. Changes in viral hepatitis B screening practices over time in West African HIV clinics. Med Mal Infect. 2017;47(6):394\u2013400.","DOI":"10.1016\/j.medmal.2017.04.011"},{"issue":"7","key":"11822_CR34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/QAD.0000000000003193","volume":"36","author":"C Hawkins","year":"2022","unstructured":"Hawkins C, Kang M, Bhattacharya D, Cloherty G, Kuhns M, Matining R, et al. Hepatitis B surface antigen and hepatitis B RNA changes in HIV\/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks. AIDS Lond Engl 1 Juin. 2022;36(7):975\u201384.","journal-title":"AIDS Lond Engl 1 Juin"},{"issue":"4","key":"11822_CR35","doi-asserted-by":"publisher","first-page":"e0215464","DOI":"10.1371\/journal.pone.0215464","volume":"14","author":"P Gantner","year":"2019","unstructured":"Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, et al. Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV\/HIV co-infection. PLoS ONE 18 Avr. 2019;14(4):e0215464.","journal-title":"PLoS ONE 18 Avr"},{"issue":"1","key":"11822_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12985-018-1050-3","volume":"15","author":"A Luo","year":"2018","unstructured":"Luo A, Jiang X, Ren H. Lamivudine plus Tenofovir combination therapy versus lamivudine monotherapy for HBV\/HIV coinfection: a meta-analysis. Virol J 10 Sept. 2018;15(1):139.","journal-title":"Virol J 10 Sept"},{"issue":"7","key":"11822_CR37","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3851\/IMP2649","volume":"18","author":"DM Gracey","year":"2013","unstructured":"Gracey DM, Snelling P, McKenzie P, Strasser SI. Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection. Antivir Ther. 2013;18(7):945\u20138.","journal-title":"Antivir Ther"},{"issue":"4","key":"11822_CR38","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/hep.27730","volume":"62","author":"HS Hwang","year":"2015","unstructured":"Hwang HS, Park CW, Song MJ. Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfection. Hepatology. 2015;62(4):1318\u201320.","journal-title":"Hepatology"},{"issue":"7","key":"11822_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4254\/wjh.v4.i7.218","volume":"4","author":"KA Attia","year":"2012","unstructured":"Attia KA, Eholi\u00e9 S, Messou E, Danel C, Polneau S, Chenal H, et al. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol 27 Juill. 2012;4(7):218\u201323.","journal-title":"World J Hepatol 27 Juill"},{"key":"11822_CR40","doi-asserted-by":"crossref","unstructured":"Weitzel T, Rodr\u00edguez F, Noriega LM, Marcotti A, Duran L, Palavecino C et al. Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey. PLoS ONE. 9 janv. 2020;15(1):e0227776.","DOI":"10.1371\/journal.pone.0227776"},{"key":"11822_CR41","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12879-017-2568-5","volume":"17","author":"PA Coffie","year":"2017","unstructured":"Coffie PA, Tchounga BK, Bado G, Kabran M, Minta DK, Wandeler G, et al. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa. BMC Infect Dis 4 Juill. 2017;17:466.","journal-title":"BMC Infect Dis 4 Juill"},{"issue":"10","key":"11822_CR42","doi-asserted-by":"publisher","first-page":"e992","DOI":"10.1016\/S2214-109X(17)30298-X","volume":"5","author":"AJ Stockdale","year":"2017","unstructured":"Stockdale AJ, Chaponda M, Beloukas A, Phillips RO, Matthews PC, Papadimitropoulos A, et al. Prevalence of hepatitis D virus infection in sub-Saharan africa: a systematic review and meta-analysis. Lancet Glob Health 11 Sept. 2017;5(10):e992\u20131003.","journal-title":"Lancet Glob Health 11 Sept"},{"key":"11822_CR43","doi-asserted-by":"crossref","unstructured":"Mbaga DS, Kenmoe S, Kengne-Nd\u00e9 C, Ebogo-Belobo JT, Mahamat G, Foe-Essomba JR et al. Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders. PLoS ONE. 21 janv. 2022;17(1):e0262903.","DOI":"10.1371\/journal.pone.0262903"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11822-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:05:34Z","timestamp":1761699934000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11822-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11822"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11822-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the National Bioethics Committee for Health Research (CBRS) of the Ministry of Health and Public Hygiene of Togo under N\u00b0 012\/2023\/CBRS of March 23, 2023 (supplementary file 2). The research was conducted in accordance with the ethical principles of the Declaration of Helsinki. Written informed consent was systematically obtained from each participant. Data collection was carried out anonymously, and the confidentiality of participants was respected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1432"}}